Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
- Status
- RECRUITING
- Phase
- N/A
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy
- Status
- COMPLETED
- Phase
- N/A
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of HS022 and Trastuzumab® in Combination With Vinorelbine Bitartrate Injection in the Treatment of HER2-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
- Status
- RECRUITING
- Phase
- N/A
Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.
- Status
- UNKNOWN
- Phase
- PHASE3
Basket Study for Oligo-metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA
89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study
- Status
- COMPLETED
- Phase
- NA
Exosome as the Prognostic and Predictive Biomarker in EBC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2